ORCID as entered in ROS

Select Publications
2023, 'Patient-led urate self-monitoring to improve allopurinol persistence and clinical outcomes in people with gout: a pilot study', in BRITISH JOURNAL OF PHARMACOLOGY, WILEY, SCOTLAND, Glasgow, pp. 288 - 290, presented at 19th World Congress of Basic and Clinical Pharmacology (WCP), SCOTLAND, Glasgow, 02 July 2023 - 07 July 2023
,2023, 'Optimising adherence to allopurinol through patient-led self-monitoring urate concentrations: gaining gout patient perspectives', in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER
,2023, 'PATIENT FACTORS AND HEALTH OUTCOMES ASSOCIATED WITH ILLNESS PERCEPTIONS IN PEOPLE WITH GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 18 - 18
,2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,